Burning Rock Biotech (BNR) Net Cash Flow (2019 - 2025)

Burning Rock Biotech's Net Cash Flow history runs 7 years deep, the most recent figure standing at $3.2 million for Q4 2025.

• In Q4 2025, Net Cash Flow rose 29.84% year-over-year to $3.2 million; the TTM figure through Dec 2025 stood at -$7.6 million (up 75.77% YoY), while the FY2025 annual figure was -$4.4 million, up 67.14% from the prior year.
• Net Cash Flow was $3.2 million for Q4 2025 at Burning Rock Biotech, up from $1.9 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $26.1 million in Q1 2021 to a low of -$37.0 million in Q3 2021.
• Historically, Net Cash Flow has averaged -$12.3 million across 5 years, with a median of -$12.5 million in 2023.
• The sharpest annual moves came in 2021 and 2024: Net Cash Flow slumped 225.21% in 2021, then soared 196.85% in 2024.
• A 5-year view of Net Cash Flow shows it stood at -$29.2 million in 2021, then gained by 22.08% to -$22.8 million in 2022, then soared by 88.7% to -$2.6 million in 2023, then jumped by 196.85% to $2.5 million in 2024, then climbed by 29.84% to $3.2 million in 2025.
• The last three Net Cash Flow figures came in at $3.2 million (Q4 2025), $1.9 million (Q3 2025), and -$9.3 million (Q2 2025), per Business Quant data.